Log In
Print
BCIQ
Print
Print this Print this
 

ISIS-CRPRx (ISIS 353512)

  Manage Alerts
Collapse Summary General Information
Company Isis Pharmaceuticals Inc.
DescriptionSecond-generation antisense inhibitor that targets C-reactive protein (CRP)
Molecular Target C-reactive protein (CRP)
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today